NEXI NexImmune Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik neximmune.com (NEXI)

Due to the neutral geopolitical status of medicine, NexImmune, Inc. (NEXI) continues to steadily advance its research. The EV/Sales trend on the GURU.Markets chart confirms the success of the standardized T-cell training method for cost reduction and the implementation of IT modeling for various tumors. Meanwhile, records a new level, verifying the current business valuation relative to revenue, excluding debt load.

Nilai perusahaan marang pendapatan: NexImmune Inc (NEXI) kanggo 04.07.2022 - 20.11.2026

neximmune.com - rincian analitis lan metrik utama (NEXI)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:NexImmune, Inc. NEXI
Sampel barang NexImmune, Inc.

NexImmune, Inc. (NEXI) innovative developments in T-cell programming and its patent protection create high business value even under strict FDA oversight. The ratio of enterprise value to revenue, reflected in the EV/Sales multiple, allows for an assessment of the market premium for R&D potential accounting for the debt load, where a downward trend on the chart signals rising operational risks.

Analisis pesaing NexImmune, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Sensei Biotherapeutics Inc SNSE|TOVX: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gritstone Bio (GRTS)|KA (Kineta Corp) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP